BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 11364224)

  • 1. Fourth protease inhibitor hits the market.
    AIDS Alert; 1997 May; 12(5):59-60. PubMed ID: 11364224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nelfinavir (Viracept) approved: fourth protease inhibitor available.
    James JS
    AIDS Treat News; 1997 Mar; (No 267):1-2. PubMed ID: 11364249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nelfinavir: fourth protease inhibitor approved.
    Crit Path AIDS Proj; 1997; (No 32):31-2. PubMed ID: 11364442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA approves nelfinavir. Food and Drug Administration.
    GMHC Treat Issues; 1997 Mar; 11(3):8. PubMed ID: 11364277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric treatments.
    AIDS Policy Law; 1997 Apr; 12(6):12. PubMed ID: 11364179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Newly approved PI provides treatment options.
    AIDS Alert; 1997 Jun; 12(6):68-9. PubMed ID: 11364360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nelfinavir - major trial results at retroviruses conference.
    AIDS Treat News; 1997 Feb; (No 265):3-4. PubMed ID: 11364240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New drug approved to treat HIV.
    Treat Rev; 1997 Apr; (No 24):5. PubMed ID: 11364284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nelfinavir (Viracept) moves up the ranks.
    Grodeck B
    Posit Aware; 1997; 8(2):16-7. PubMed ID: 11364452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nelfinavir (Viracept).
    Baker R; Bowers M
    BETA; 1997 Mar; ():5. PubMed ID: 11364528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA rapidly approves HIV protease inhibitors for children.
    Fox JL
    Nat Biotechnol; 1997 May; 15(5):404. PubMed ID: 9131607
    [No Abstract]   [Full Text] [Related]  

  • 12. Nelfinavir combination therapy: ten-month report.
    AIDS Treat News; 1997 Apr; (No 269):3. PubMed ID: 11364253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II/III Trials of Viracept start.
    AIDS Patient Care STDS; 1996 Jun; 10(3):187. PubMed ID: 11361632
    [No Abstract]   [Full Text] [Related]  

  • 14. Nelfinavir is number 4 -- but should it bat cleanup, or lead off?
    Mascolini M
    J Int Assoc Physicians AIDS Care; 1997 Jun; 3(6):17-21. PubMed ID: 11364427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nelfinavir at six months.
    PI Perspect; 1997 Mar; (No 21):11-2. PubMed ID: 11364207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New protease inhibitor available through expanded access.
    Posit Aware; 1996; 7(6):7. PubMed ID: 11363981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New protease inhibitor for children.
    Vazquez E
    Posit Aware; 1997; 8(2):11. PubMed ID: 11364449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saquinavir (Invirase): first protease inhibitor approved--reimbursement, information hotline numbers.
    James JS
    AIDS Treat News; 1995 Dec; (no 237):1-2. PubMed ID: 11363073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nelfinavir (Viracept) price increase 4.6 percent.
    AIDS Treat News; 1998 Oct; (No 305):3-4. PubMed ID: 11365867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large trial started for Viracept.
    AIDS Alert; 1997 Mar; 12(3):36. PubMed ID: 11364193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.